Assessment of chemotherapy-induced anemia in children with cancer

Central European Journal of Medicine

Volumn 3, Issue 3, 2008, Pages 341-345

  Ruggiero, Antonio ^a   Attinà, Giorgio ^a   Haber, Melina ^a   Coccia, Paola ^a   Lazzareschi, Ilaria ^a   Riccardi, Riccardo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Anemia; Cancer; Chemotherapy induced anemia; Children; Transfusion

Indexed keywords

CYTOTOXIC AGENT; PLATINUM;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER GRADING; CHEMOTHERAPY INDUCED ANEMIA; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; FEMALE; GERM CELL TUMOR; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDULLOBLASTOMA; NEPHROBLASTOMA; NEUROBLASTOMA; OSTEOSARCOMA; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SOLID TUMOR; TREATMENT DURATION;

EID: 47249123706     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-008-0049-3     Document Type: Article

References (17)

1. Leitgeb C., Pecherstorfer M., Fritz E., Ludwig H., Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin, Cancer, 1994, 73(10), 2535-42
2. Corazza F., Beguin Y., Bergmann P., Andre M., Ferster A., Devalck C., Fondu P., Buyse M., Sariban E., Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production, Blood, 1998, 92(5),1793-8
3. Lai J.S., Cella D., Kupst M.J., Holm S., Kelly M.E., Bode R.K., Goldman S., Measuring fatigue for children with cancer: development and validation of the pediatric Functional Assessment of Chronic Illness Therapy-Fatigue (pedsFACIT-F), J. Pediatr. Hematol. Oncol., 2007, 29(7), 471-9
4. Jelkmann W., Developments in the therapeutic use of erythropoiesis stimulating agents, Br. J. Haematol., 2008, 141(3), 287-97
5. Dainiak N., Kulkarni V., Howard D., Kalmanti M., Dewey M.C., Hoffman R., Mechanisms of abnormal erythropoiesis in malignancy, Cancer, 1983, 51(6), 1101-6
6. Ludwig H., Fritz E., Anemia in cancer patients, Semin. Oncol. 1998, 25(3 Suppl 7), 2-6
7. Ludwig H., Epoetin in cancer-related anaemia, Nephrol. Dial. Transplant., 1999, 14(S2), 85-92
8. Mercadante S., Gebbia V., Marrazzo A., Filosto S., Anaemia in cancer: pathophysiology and treatment, Cancer Treat. Rev., 2000, 26(4), 303-11
9. Shankar A.G., The role of recombinant erythropoietin in childhood cancer, Oncologist,. 2008, 13(2),157-66
10. Means R.T. Jr, Krantz S.B., Progress in understanding the pathogenesis of the anemia of chronic disease, Blood, 1992, 80(7),1639-47
11. Groopman J.E., Itri L.M., Chemotherapy-induced anemia in adults: incidence and treatment, J. Natl. Cancer Inst., 1999, 91(19), 1616-34. Erratum in: J. Natl. Cancer Inst., 2000, 92(6), 497
12. Ruggiero A., Riccardi R., Interventions for anemia in pediatric cancer patients, Med. Pediatr. Oncol., 2002,39(4),451-4
13. Miller C.B., Jones R.J., Piantadosi S., Abeloff M.D., Spivak J.L., Decreased erythropoietin response in patients with the anemia of cancer, N. Engl. J. Med., 1990, 322(24), 1689-92
14. Adamson J.W., Ludwig H., Predicting the hematopoietic response to recombinant human erythropoietin (Epoetin alfa) in the treatment of the anemia of cancer, Oncology, 1999, 56(1), 46-53
15. Schapira L., Antin J.H., Ransil B.J., Antman K.H., Eder J.P., McGarigle C.J., Goldberg M.A., Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy, Blood, 1990, 76(11), 2354-9
16. Marc-Berad P., Blay J.K., Schell M., Buclon M., Demaret C., Ray-Coquard I., Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patients, J. Clin. Oncol., 2003, 21, 4235-9
17. Cascinu S., Fedeli A., Luzi Fedeli S., Catalano G., Cisplatin-associated anemia treated with subcutaneous erythropoietin. A pilot study, Br. J. Cancer, 1993, 67, 156-58